Study: Anti-Obesity Medication Twice as Effective as Most Weight Loss Drugs
February 16th 2021One-third of study participants treated with semaglutide lost at least 20% (46 pounds) of their baseline weight, which is a common reduction for many patients who have had bariatric surgery in the 1 to 3 years following their procedure.
Read More
COVID-19 Pandemic ‘Unveiled’ Preexisting Racial Disparities in Health Care
February 15th 2021In a discussion regarding racial disparities and impediments to getting more people of color vaccinated, Laurie Zephyrin, MD, MPH, MBA, vice president of the delivery system reform at The Commonwealth Fund, explained some of the key factors.
Read More
Study: Goldenseal Use May Compromise Glucose Control in Diabetics
February 15th 2021The objective of the study was to determine the impact of goldenseal on specific drug transporters, proteins that facilitate absorption or expulsion of drug molecules in different tissues, such as the intestine, liver, and kidney.
Read More
FDA Approves Treatment for Chemotherapy-Induced Bone Marrow Suppression in Small Cell Lung Cancer
February 15th 2021The FDA has approved trilaciclib (Cosela) to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage small cell lung cancer.
Read More
Nutritional Counseling Should Be Included in Cancer Treatment, Preventive Efforts
February 12th 2021Investigators found that poor diets are particularly common among adult cancer survivors who have significant sociodemographic disparities, including those who have less formal education and those who are overweight.
Read More
Fun Fact: How Did a Man in the 19th Century Miraculously Cure Himself From Certain Death?
February 12th 2021In the early 19th century, hydropathic institutes became all the rage after Priessnitz miraculously healed himself following a rib injury that his doctor had proclaimed would lead to certain death.
Read More
FDA Approves First-in-Class Therapy for Ultra-Rare Form of High Cholesterol
February 12th 2021Evinacumab-dgnb (Evkeeza; Regeneron Pharmaceuticals, Inc.) is the first FDA-approved treatment that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3), a protein that plays a key role in lipid metabolism.
Read More